ELDN · Eledon Pharmaceuticals, Inc.
$3.40
-0.17 (-4.76%)
At close · Jul 28
Market Cap
$275.56M
Shares
77.19M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-22 | 2026-06-18 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | 2026-06-18 | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-01-02 | 2025-12-30 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 8-K | 2025-11-07 | 2025-11-06 | |
| 8-K | 2025-08-14 | 2025-08-11 | |
| 10-Q/A | 2025-08-14 | 2025-03-31 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 10-K/A | 2025-08-14 | 2024-12-31 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-29 | 2025-06-10 | |
| 8-K/A | 2025-04-14 | 2025-04-01 | |
| 8-K | 2025-04-07 | 2025-04-01 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2024-12-20 | 2024-12-16 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-30 | 2024-10-29 | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-10-01 | 2024-09-30 | |
| 8-K | 2024-09-20 | — | |
| 10-K/A | 2024-08-19 | 2023-12-31 | |
| 10-Q/A | 2024-08-19 | 2024-03-31 | |
| 10-Q | 2024-08-19 | 2024-06-30 | |
| 8-K | 2024-08-14 | 2024-08-13 | |
| 8-K | 2024-07-12 | 2024-07-10 | |
| 8-K | 2024-07-10 | 2024-07-08 | |
| 8-K | 2024-07-10 | — | |
| DEF 14A | 2024-05-30 | 2024-07-10 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-13 | 2024-05-09 | |
| 8-K | 2024-05-07 | 2024-05-06 | |
| 10-K/A | 2024-04-26 | 2023-12-31 | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-10-02 | 2023-09-29 | |
| 8-K | 2023-09-21 | 2023-09-20 |
Showing 1–50 of 110 filings
Key facts
CIK
1404281
CUSIP
28617K101
13F (30d)
32 filings
32 filers
Visit website
Investor relations